Leerink Partners Lowers Repligen Earnings Forecast: What Investors Need to Know
Leading equities research firm Leerink Partners recently made waves in the biotechnology sector by revising its earnings per share estimates downward for Repligen Corporation (NASDAQ:RGEN), a move…